Radius Health, Inc. (RDUS): Price and Financial Metrics


Radius Health, Inc. (RDUS): $12.18

0.06 (+0.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

RDUS POWR Grades


  • Value is the dimension where RDUS ranks best; there it ranks ahead of 93.06% of US stocks.
  • The strongest trend for RDUS is in Momentum, which has been heading down over the past 47 weeks.
  • RDUS's current lowest rank is in the Sentiment metric (where it is better than 5.95% of US stocks).

RDUS Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for RDUS is -1.1 -- better than just 3.62% of US stocks.
  • RDUS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 4.65% of US stocks.
  • With a year-over-year growth in debt of 53.5%, Radius Health Inc's debt growth rate surpasses 87.1% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Radius Health Inc, a group of peers worth examining would be AKBA, GPL, INSM, INFN, and MDWD.
  • Visit RDUS's SEC page to see the company's official filings. To visit the company's web site, go to www.radiuspharm.com.

RDUS Valuation Summary

  • In comparison to the median Healthcare stock, RDUS's EV/EBIT ratio is 183.28% lower, now standing at -24.4.
  • RDUS's price/earnings ratio has moved down 10.9 over the prior 88 months.
  • Over the past 88 months, RDUS's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for RDUS.

Stock Date P/S P/B P/E EV/EBIT
RDUS 2021-08-31 2.6 -2.9 -10.9 -24.4
RDUS 2021-08-30 2.6 -2.8 -10.7 -24.1
RDUS 2021-08-27 2.6 -2.8 -10.7 -24.1
RDUS 2021-08-26 2.5 -2.8 -10.4 -23.6
RDUS 2021-08-25 2.6 -2.8 -10.6 -23.9
RDUS 2021-08-24 2.6 -2.8 -10.7 -24.1

RDUS Growth Metrics

  • Its 5 year net income to common stockholders growth rate is now at -48.28%.
  • Its 2 year net cashflow from operations growth rate is now at 63.8%.
  • The 3 year price growth rate now stands at -29.62%.
RDUS's revenue has moved up $75,350,000 over the prior 18 months.

The table below shows RDUS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 248.667 -61.983 -60.233
2021-03-31 246.983 -59.876 -87.303
2020-12-31 238.645 -73.948 -109.208
2020-09-30 231.527 -54.003 -112.538
2020-06-30 200.467 -74.765 -136.293
2020-03-31 191.396 -81.135 -127.887

RDUS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • RDUS has a Quality Grade of C, ranking ahead of 70.86% of graded US stocks.
  • RDUS's asset turnover comes in at 1.266 -- ranking 13th of 677 Pharmaceutical Products stocks.
  • FOLD, ADMS, and CLVS are the stocks whose asset turnover ratios are most correlated with RDUS.

The table below shows RDUS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.266 0.929 -0.122
2021-03-31 1.287 0.930 -0.218
2020-12-31 1.249 0.928 -0.297
2020-09-30 1.170 0.926 -0.307
2020-06-30 0.974 0.914 -0.387
2020-03-31 0.858 0.912 -0.347

RDUS Price Target

For more insight on analysts targets of RDUS, see our RDUS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $22.14 Average Broker Recommendation 1.93 (Hold)

RDUS Stock Price Chart Interactive Chart >

Price chart for RDUS

RDUS Price/Volume Stats

Current price $12.18 52-week high $26.16
Prev. close $12.12 52-week low $10.15
Day low $11.95 Volume 317,329
Day high $12.26 Avg. volume 382,251
50-day MA $14.49 Dividend yield N/A
200-day MA $18.50 Market Cap 575.70M

Radius Health, Inc. (RDUS) Company Bio


Radius Health is a biopharmaceutical company focused on developing new therapeutics for patients with advanced osteoporosis as well as other serious endocrine-mediated diseases including hormone responsive metastatic breast cancer. The company was founded in 2003 and is based in Waltham, Massachusetts.


RDUS Latest News Stream


Event/Time News Detail
Loading, please wait...

RDUS Latest Social Stream


Loading social stream, please wait...

View Full RDUS Social Stream

Latest RDUS News From Around the Web

Below are the latest news stories about Radius Health Inc that investors may wish to consider to help them evaluate RDUS as an investment opportunity.

Radius Health Inc (RDUS): Price Down $-0.2 (-1.46)% Over Past Day, Up $0.08 (0.6)% Over Past Hour

If you''re a trend trader, consider that the strongest clear trend on the daily chart exists on the 100 day timeframe. The post Radius Health Inc (RDUS): Price Down $-0.2 (-1.46)% Over Past Day, Up $0.08 (0.6)% Over Past Hour appeared first on ETF Daily News .

ETF Daily News | September 3, 2021

Radius Health Inc (RDUS): Price Now Near $13.46; Daily Chart Shows Downtrend on 100 Day Basis

If you''re a trend trader, consider that the strongest clear trend on the hourly chart exists on the 50 hour timeframe. The post Radius Health Inc (RDUS): Price Now Near $13.46; Daily Chart Shows Downtrend on 100 Day Basis appeared first on ETF Daily News .

ETF Daily News | August 26, 2021

Loss-Making Radius Health, Inc. (NASDAQ:RDUS) Expected To Breakeven In The Medium-Term

We feel now is a pretty good time to analyse Radius Health, Inc.'s ( NASDAQ:RDUS ) business as it appears the company...

Yahoo | August 9, 2021

Radius Health (RDUS) Q2 2021 Earnings Call Transcript

RDUS earnings call for the period ending June 30, 2021.

Yahoo | August 7, 2021

Radius (RDUS) Q2 Loss Narrower Than Expected, Revenues Lag

Radius (RDUS) reports a narrower loss but misses on sales in the second quarter. The company also lowers guidance for lead drug Tymlos.

Yahoo | August 6, 2021

Read More 'RDUS' Stories Here

RDUS Price Returns

1-mo -10.64%
3-mo -34.27%
6-mo -45.82%
1-year -2.87%
3-year -31.50%
5-year -77.90%
YTD -31.80%
2020 -11.41%
2019 22.26%
2018 -48.10%
2017 -16.46%
2016 -38.20%

Continue Researching RDUS

Want to see what other sources are saying about Radius Health Inc's financials and stock price? Try the links below:

Radius Health Inc (RDUS) Stock Price | Nasdaq
Radius Health Inc (RDUS) Stock Quote, History and News - Yahoo Finance
Radius Health Inc (RDUS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9909 seconds.